Authors:
Craven, J
Bjorn, H
Hennessy, D
Friis, C
Nansen, P
Citation: J. Craven et al., Pharmacokinetics of moxidectin and ivermectin following intravenous injection in pigs with different body compositions, J VET PHARM, 24(2), 2001, pp. 99-104
Authors:
Acar, J
Casewell, M
Freeman, J
Friis, C
Goossens, H
Citation: J. Acar et al., Avoparcin and virginiamycin as animal growth promoters: a plea for sciencein decision-making, CL MICRO IN, 6(9), 2000, pp. 477-482
Citation: Mt. Skaanild et C. Friis, Expression changes of CYP2A and CYP3A in microsomes from pig liver and cultured hepatocytes, PHARM TOX, 87(4), 2000, pp. 174-178
Citation: Rh. Lindecrona et al., Pharmacokinetics and penetration of danofloxacin into the gastrointestinaltract in healthy and in Salmonella typhimurium infected pigs, RES VET SCI, 68(3), 2000, pp. 211-216
Citation: Rh. Lindecrona et al., The pharmacodynamic effect of amoxicillin and danofloxacin against Salmonella typhimurium in an in-vitro pharmacodynamic model, RES VET SCI, 68(3), 2000, pp. 261-264
Citation: H. Agerso et al., Pharmacokinetics and tissue distribution of amoxicillin in healthy and Salmonella Typhimurium-inoculated pigs, AM J VET RE, 61(8), 2000, pp. 992-996
Citation: Mb. Petersen et C. Friis, Pharmacokinetics of fenbendazole following intravenous and oral administration to pigs, AM J VET RE, 61(5), 2000, pp. 573-576
Citation: Rh. Lindecrona et al., The pharmacodynamic effect of amoxycillin and danofloxacin against Actinobacillus pleuropneumoniae in an in-vitro pharmacodynamic model, RES VET SCI, 67(1), 1999, pp. 93-97